# Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

> **NCT02998541** · PHASE3 · TERMINATED · sponsor: **Shire** · enrollment: 219 (actual)

## Conditions studied

- Adenoviral Conjunctivitis

## Interventions

- **DRUG:** SHP640
- **DRUG:** PVP-I 0.6%
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02998541
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-05-13
- **Final completion:** 2019-05-13
- **Target enrollment:** 219 (ACTUAL)
- **Why stopped:** Sponsor decision, unrelated to safety
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998541, "Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02998541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*